Related topics: cancer , hepatitis c , liver , hepatitis b
Liver cancer
hideLiver cancer is a cancer that starts in the liver. For a thorough understanding of liver cancer it is important to know a brief summary of how the liver works and functions. The liver is the largest organ in the body. It is located below the right lung and under the ribcage. The liver is divided into two lobes: the right lobe and left lobe. Protein is obtained by the liver from a set of sources. The portal vein carries nutrient rich blood from the intestines to the liver and the hepatic artery supplies the liver with blood that is rich in oxygen. Multiple types of tumors can develop in the liver because the liver is made up of many various cells. Tumors that are cancerous are termed malignant and tumors that do not contain cancer are termed benign. Liver cancer is characterized by the presence of malignant hepatic tumors -- tumors or growths on or in the liver (medical terms pertaining to the liver often start in hepato- or hepatic from the Greek word for liver, hēpar, stem hēpat-). They may be discovered on medical imaging (even for a different reason than the cancer itself), or may be present in patients as an abdominal mass, abdominal pain, jaundice, or some other liver dysfunction.
For more information about Liver cancer, read the full article at
Wikipedia.
This text uses material from Wikipedia and is available under the GNU Free Documentation License.
News tagged with liver cancer
Scientists Uncover Protective Mechanism Against Liver Cancer
Dec 14, 2009 |
4 / 5 (1) |
0
(PhysOrg.com) -- A team of scientists from the UC San Diego School of Medicine and Osaka University in Japan have identified a protein switch that helps prevent liver damage, including inflammation, fibrosis and cancer. The ...
First live targeting of tumors with RNA-based technology
Nov 30, 2009 |
4 / 5 (1) |
0
(PhysOrg.com) -- Finding and treating a tumor without disturbing normal tissue presents challenges - sometimes the most effective therapies can be invasive and harsh.
Trigger of deadly food toxin discovered
Oct 21, 2009 |
4.7 / 5 (3) |
0
(PhysOrg.com) -- A toxin produced by mold on nuts and grains can cause liver cancer if consumed in large quantities. UC Irvine researchers for the first time have discovered what triggers the toxin to form, ...
A Twist in the Genome Thwarts Hepatitis C
Sep 30, 2009 |
not rated yet |
0
(PhysOrg.com) -- Viruses like Hepatitis C proliferate by tricking cellular machinery into manufacturing the parts for duplicate viral particles.
Study shows promise for new cancer-stopping therapy
Jun 11, 2009 |
3.4 / 5 (5) |
2
Researchers at Nationwide Children's Hospital and Johns Hopkins University have discovered that delivering a small molecule that is highly expressed in normal tissues but lost in diseased cells can result in tumor suppression.
Stem cell protein offers a new cancer target
Jun 01, 2009 |
not rated yet |
0
A protein abundant in embryonic stem cells is now shown to be important in cancer, and offers a possible new target for drug development, report researchers from the Stem Cell Program at Children's Hospital Boston.
If metastasectomy should be performed before other treatments
Oct 31, 2008 |
4.7 / 5 (3) |
0
Primary HCC is a major cancer related to HBV viral infection in Asian countries, including Japan. Recently, the primary liver cancers are successfully treated by surgical resection including liver transplantation and non-surgical ...
Higher coffee consumption associated with lower liver cancer risk
Jun 26, 2008 |
4.7 / 5 (21) |
3
A new large, prospective population-based study confirms an inverse relationship between coffee consumption and liver cancer risk. The study also found that higher levels of gamma-glutamyltransferase (GGT) in the blood were ...
New data show breakthrough microRNA-targeted therapy holds promise as new treatment for hepatitis C
Dec 03, 2009 |
5 / 5 (1) |
0
A study published online in this week's Science shows that SPC3649, a breakthrough microRNA-targeted therapy developed by Santaris Pharma A/S, holds promise as a novel treatment for patients infected with the Hepatitis C viru ...
Research isolates liver cancer stem cells prior to tumor formation
Sep 17, 2009 |
5 / 5 (1) |
0
Penn State College of Medicine researchers, in collaboration with colleagues at the University of Southern California, have taken an important step in understanding the role of stem cells in development of liver cancer. Using ...
Current hepatitis C treatments work equally well, researchers report
Aug 07, 2009 |
not rated yet |
0
The three treatment combinations for clearing the most common form of the hepatitis C virus work equally well with similar side effects, UT Southwestern Medical Center researchers and their colleagues in 13 ...
Researchers identify genes linked to chemoresistance
Jul 20, 2009 |
5 / 5 (1) |
0
Two genes may contribute to chemotherapy resistance in drugs like 5-fluorouracil, which is used in liver cancer treatment, according to Virginia Commonwealth University Massey Cancer Center researchers.
NY hospital warns of possible hepatitis exposures
Jul 16, 2009 |
not rated yet |
0
(AP) -- A hospital in New York state is notifying about 2,800 patients of possible exposure to hepatitis C after learning that a former employee is suspected of exposing nearly 6,000 patients in Colorado to the disease.
Good news for some hard-to-treat hepatitis C patients
Jun 16, 2009 |
not rated yet |
0
In a multi-center trial led by a Saint Louis University researcher, investigators found that a new combination therapy of daily consensus interferon and ribavirin helps some hepatitis C patients who have not responded to ...
Low-fat diet helps genetically predisposed animals avoid liver cancer
Jun 12, 2009 |
not rated yet |
1
In a study comparing two strains of mice, one susceptible to developing cancer and the other not, researchers found that a high-fat diet predisposed the cancer-susceptible strain to liver cancer, and that by switching to ...
